Veru Inc.

Company Listings from SPi: Veru Inc.

You are here: Home >> SPi Company Listings >> Veru Inc.

 

Veru Inc.

Website:
http://

Search for other references to "veru" on SPi News

Latest Veru Inc. News

Veru to Participate in Two Investor Conferences in March MIAMI, March 12, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for the prostate cancer continuum...... 12:00 GMT Tuesday 12th March 2019

Veru Reports Strong Fiscal 2019 First Quarter Financial Results    MIAMI, Feb. 13, 2019 (GLOBE NEWSWIRE) --  Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for the prostate cancer con...... 11:30 GMT Wednesday 13th February 2019

Veru Announces Scientific Presentations for Novel Prostate Cancer Drug Candidates at the 2019 American Society of Clinical Oncology Genitourinary Cancers Symposium MIAMI, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for the prostate cancer continuum...... 13:00 GMT Tuesday 12th February 2019

Veru to Report Fiscal 2019 First-Quarter Financial Results, Host Conference Call on February 13th MIAMI, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company developing novel medicines for the prostate cancer continuum...... 13:30 GMT Wednesday 6th February 2019

Veru Initiates Clinical Trial for Proprietary, Novel, First-in-Class Drug for Advanced Prostate Cancer MIAMI, Jan. 22, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that it has initiated and enrolled the first...... 13:30 GMT Tuesday 22nd January 2019

Veru Announces Acceptance of Four Abstracts for Presentation at the Genitourinary Cancer Symposium in February 2019 MIAMI, Jan. 15, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that four abstracts have been accepted for p...... 13:00 GMT Tuesday 15th January 2019

Veru Announces Successful Bioavailability and Bioequivalence Clinical Trial for Tadalafil and Finasteride Combination Tablet for Benign Prostatic Hyperplasia MIAMI, Jan. 14, 2019 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that the clinical trial of the Company’s p...... 13:00 GMT Monday 14th January 2019

Veru Reports Strong Net Revenues and Gross Profit for Fiscal 2018 Fourth-Quarter MIAMI, Dec. 13, 2018 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU) today announced its financial results for the fiscal (FY) 2018 fourth-quarter and full-year ended September 30,...... 11:30 GMT Thursday 13th December 2018

Veru to Report Fiscal Year 2018 Financial Results, Host Conference Call on December 13th MIAMI, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, today announced that on Thursday, December 13, 2018, the com...... 13:30 GMT Thursday 6th December 2018

Veru Announces First Patient Dosed in Bioequivalence Clinical Trial for Combination Tadalafil – Finasteride Tablet for Benign Prostatic Hyperplasia MIAMI, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology and urology biopharmaceutical company, announced today that the Company has dosed its first patient...... 13:30 GMT Monday 3rd December 2018

Buy Veru Inc.
Market Reports
from SPi

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us